What is the clinical evidence from this study?

Study design: Case Report. Population: Atrial arrhythmias (paroxysmal AT / AFL / AF) originating from the superior vena cava (n=3). Intervention: Radiofrequency ablation of the superior vena cava. Primary outcome: Freedom from symptomatic arrhythmia recurrence.

What does this research mean for the field?

Superior vena cava ectopy can present with variable conduction into the right atrium, mimicking sinus rhythm, atrial tachycardia, atrial flutter, or atrial fibrillation. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the clinical presentations, mapping approaches, and procedural outcomes of catheter ablation targeting superior vena cava ectopy responsible for triggering paroxysmal atrial arrhythmias.

October 4, 2026SA HeartOpen Access

Atrial arrhythmias arising from the Superior Vena Cava presenting as paroxysmal Atrial fibrillation and Atrial tachycardia

View Full Paper

Ask AI

Bookmark

Key result

SVC ablation achieves 100% long-term freedom from recurrent atrial arrhythmias triggered by SVC ectopy.

Why the study?

The Superior Vena Cava harbours 25%-40% of non-pulmonary vein foci in AF and can manifest as paroxysmal AT, with AF ablation focusing on pulmonary vein isolation alone potentially missing SVC ectopy and causing procedural failure.

Does radiofrequency ablation of SVC-origin tachycardia prevent recurrent arrhythmias in patients with paroxysmal AF, AFL, or AT?

Key Points

To evaluate the clinical presentations, mapping approaches, and procedural outcomes of catheter ablation targeting superior vena cava ectopy responsible for triggering paroxysmal atrial arrhythmias.
Retrospective review of N=3 patients with superior vena cava-origin ectopy-induced atrial arrhythmias identified among 323 patients undergoing ablation between 2009 and 2023.
Patients underwent electrophysiological study and 3D electroanatomical mapping to direct either focal radiofrequency ablation or superior vena cava isolation.
All 3 patients achieved successful ablation of superior vena cava-origin tachycardia with no symptomatic recurrences reported during follow-up.
Procedural complications occurred in 2 patients, consisting of asymptomatic sinus node dysfunction in 1 patient and gastroparetic symptoms likely caused by right vagal nerve injury in 1 patient that resolved over 2 years.

Study Design

Type

Case Report (n=3)

Multicenter

Structured PICO

Does radiofrequency ablation of SVC-origin tachycardia prevent recurrent arrhythmias in patients with paroxysmal AF, AFL, or AT?

Population

3 patients (aged 31-52 years, 1 female) with paroxysmal atrial fibrillation, flutter, or focal atrial tachycardia originating from the superior vena cava who underwent successful radiofrequency ablation and were followed for 4 to 12 years.

Intervention

Radiofrequency ablation of SVC-origin tachycardia (focal ablation or SVC isolation) using 3D mapping.

Outcome

Successful ablation and freedom from recurrent symptoms during follow-up.

Ablation of SVC ectopy is an effective curative strategy for paroxysmal atrial arrhythmias originating from the SVC, though care must be taken to avoid injury to the adjacent vagus and sinus nodes.

Limitations

Small sample size of only 3 patients
Retrospective analysis
Risk of complications including vagus nerve and sinus node injury, which occurred in two of the patients

Implication

Supports SVC ablation in select refractory cases; hypothesis-generating and requires prospective validation before broader adoption.

Abstract

The Superior vena cava (SVC) harbours about 25%-40% of the non-pulmonary vein foci in Atrial Fibrillation (AF) and could manifest itself as paroxysmal Atrial Tachycardia (AT). AF ablation focusing on pulmonary vein isolation alone could miss SVC ectopy and result in failure of the procedure. Successful ablation is usually curative in SVC ectopy-induced AT/AF, however, potential complications include injury to the Phrenic nerve, Vagus nerve or the Sino-Atrial node. A focal ablation approach or SVC Isolation are both proven options in the management of SVC tachycardia. In this case series, we report SVC ectopy with variable conduction into the right atrium mimicking sinus rhythm, AT, Atrial Flutter (AFL) or AF.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dar et al. (2024) conducted a case report in Atrial arrhythmias (paroxysmal AT / AFL / AF) originating from the superior vena cava (n=3). Radiofrequency ablation of the superior vena cava was evaluated on Freedom from symptomatic arrhythmia recurrence. Radiofrequency ablation of the superior vena cava successfully eliminated paroxysmal atrial arrhythmias originating from SVC ectopy in all three patients, with no recurrences during 4 to 12 years of follow-up.

synapsesocial.com/papers/6ac1aba6cc6172083c928aca https://doi.org/10.24170/21-1-6332

Topics

Atrial fibrillation

Persistent AF management

AF ablation outcomes

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Implication

Supports SVC ablation in select refractory cases; hypothesis-generating and requires prospective validation before broader adoption.

Atrial arrhythmias arising from the Superior Vena Cava presenting as paroxysmal Atrial fibrillation and Atrial tachycardia

Key Points

Study Design

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Topics

Atrial arrhythmias arising from the Superior Vena Cava presenting as paroxysmal Atrial fibrillation and Atrial tachycardia

Key Points

Study Design

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Topics

Keep reading